Staged ocular fornix reconstruction for glaucoma drainage device under neoconjunctiva at the time of Boston type 1 Keratoprosthesis implantation
- PMID: 30742989
- DOI: 10.1016/j.jtos.2019.01.010
Staged ocular fornix reconstruction for glaucoma drainage device under neoconjunctiva at the time of Boston type 1 Keratoprosthesis implantation
Abstract
Purpose: Glaucoma is the leading cause of vision loss in eyes with Boston Keratoprosthesis (KPro). Glaucoma drainage devices (GDDs) have been shown to be effective in controlling glaucoma with KPro. Cicatricial conjunctival disease with forniceal shortening is a major challenge and limitation to the use of GDD. In our series, we report the success of fornix reconstruction in cicatricial ocular surface disease as a staged procedure prior to a combined KPro/GDD surgery.
Methods: Retrospective case series involving 4 eyes with surface cicatricization. Three patients with chemical burns and one patient with Ectrodactyly Ectodermal Dysplasia-Clefting syndrome. Preoperative data, surgical interventions, and clinical outcomes were reviewed.
Conclusion: This series represents the first report of fornix reconstruction for combined KPro/GDD surgery. Fornix reconstruction with the aid of AMT with or without OMM grafting is a relatively safe and effective way to manage complex cicatricial surface disease associated with corneal scarring and glaucoma, allowing for subsequent successful implantation of GDD and KPro in cases that were otherwise poor surgical candidates.
Keywords: Boston Keratoprosthesis; Fornix reconstruction; Glaucoma drainage device; Neoconjunctiva.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
Safety of Concurrent Boston Type I Keratoprosthesis and Glaucoma Drainage Device Implantation.Ophthalmology. 2017 Jan;124(1):12-19. doi: 10.1016/j.ophtha.2016.08.003. Epub 2016 Sep 7. Ophthalmology. 2017. PMID: 27614591
-
Incidence, risk factors, and treatment of retroprosthetic membranes following Boston keratoprosthesis eyes and the impact of glaucoma surgery.Graefes Arch Clin Exp Ophthalmol. 2024 Aug;262(8):2561-2567. doi: 10.1007/s00417-024-06445-6. Epub 2024 Mar 19. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 38502349
-
Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices.Br J Ophthalmol. 2013 May;97(5):573-7. doi: 10.1136/bjophthalmol-2012-302770. Epub 2013 Feb 23. Br J Ophthalmol. 2013. PMID: 23435225
-
The Boston Keratoprosthesis-The First 50 Years: Some Reminiscences.Annu Rev Vis Sci. 2022 Sep 15;8:1-32. doi: 10.1146/annurev-vision-100820-021253. Epub 2022 Jul 14. Annu Rev Vis Sci. 2022. PMID: 35834821 Review.
-
Systematic Review and Meta-Analysis of the Medium- and Long-Term Outcomes of the Boston Type 1 Keratoprosthesis.Cornea. 2019 Nov;38(11):1465-1473. doi: 10.1097/ICO.0000000000002098. Cornea. 2019. PMID: 31403526
Cited by
-
Critical media attributes in E-beam sterilization of corneal tissue.Acta Biomater. 2022 Jan 15;138:218-227. doi: 10.1016/j.actbio.2021.10.033. Epub 2021 Oct 28. Acta Biomater. 2022. PMID: 34755604 Free PMC article.
-
Toward electron-beam sterilization of a pre-assembled Boston keratoprosthesis.Ocul Surf. 2021 Apr;20:176-184. doi: 10.1016/j.jtos.2021.02.009. Epub 2021 Mar 3. Ocul Surf. 2021. PMID: 33667673 Free PMC article.
-
Treatment of Oculoplastic and Ocular Surface Disease in Eyes Implanted with a Type I Boston Keratoprosthesis in Southern China: A Retrospective Study.Adv Ther. 2020 Jul;37(7):3206-3222. doi: 10.1007/s12325-020-01381-3. Epub 2020 May 20. Adv Ther. 2020. PMID: 32436025
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical